Coronary vasospasm - A clinically relevant problem?;Koronarer Spasmus - Ein klinisch relevantes Problem?

Herz

Volumn 23, Issue 2, 1998, Pages 106-115

  Auch Schwelk, Wolfgang ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Acetylcholine; Coronary vasospasm; Endothelium; Ergonovine; Serotonin; Syncope; Variant angina

Indexed keywords

ACETYLSALICYLIC ACID;

CIGARETTE SMOKING; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; CORONARY RISK; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; MORTALITY; PREVALENCE; REVIEW; VARIANT ANGINA PECTORIS;

EID: 0031959990     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03044541     Document Type: Review

References (82)

1. Auch-Schwelk W, Maslenkowa T, Paetsch I, Oswald H, Wellnhofer E, Fleck E. Unterschiedliche Inzidenz positiver Befunde bei der Provokation von Koronarspasmen mit Ergonovin oder Methergin. Z Kardiol 1997;86:67.abstract.
2. Auch-Schwelk W, Paetsch I, Hetzer R, Fleck E. Different contractile effects of ergonovine and methylergonovine in isolated human coronary arteries. J Am Coll Cardiol 1996;27: 109A.abstract.
3. Auch-Schwelk W, Paetsch I, Hetzer R, Fleck E Thromboxane-induced supersensitivity to ergonovine in isolated human coronary arteries as a model for coronary vasospasm. Eur Heart J 1996;17:90.abstract.
4. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Chahine RA. Frequency of provoked coronary arterial spasm in 1089 consecutive patients undergoing coronary arteriography. Circulation 1982;65:1299-306.
5. Bertrand ME, Lablanche JM, Tilmant PY, Thieuleux FA, Delforge MR, Chahine RA. The provocation of coronary arterial spasm in patients with recent transmural myocardial infarction. Eur Heart J 1983;4:532-5.
6. Bory M, Joly P, Bonnet J-L, Djiane P, Serradimigni A, Methergin® testing with angiographically normal coronary arteries. Am J Cardiol 1988;61:298-302.
7. Bory M, Pierron F, Panagides D, Bonnet JL, Yvorra S, Desfossez L. Coronary artery spasm in patients with normal or near normal coronary arteries. Long-term follow-up of 277 patients. Eur Heart J 1996;17:1015-21.
8. Bott-Silverman C, Heupler FA. Natural history of pure coronary artery spasm in patients treated medically. J Am Coll Cardiol 1983,2:200-5
9. Brazenor RM, Angus JA. Ergometrine contracts isolated canine coronary arteries by a serotoninergic mechanism: no role for alpha adrenoceptors. J Pharmacol Exp Ther 1981;218:530-6.
10. Bredberg U, Eyjolfsdottir GS, Paalzow L, Tfelt-Hansen P, Tfelt-Hansen V. Pharmacokinetics of methysergide and its metabolite methylergometrine in man. Eur J Clin Pharmacol 1986;30:75-7.
11. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992;85:905-9.
12. Chahine RA, Feldman RL, Giles Tdet al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. J Am Coll Cardiol 1998;21:1365-70.
13. Chester AH, Martin GR, Bodelsson M et al. 5-Hydroxytryptamine receptor profile in healthy and diseased human coronary arteries. Cardiovasc Res 1990;24:932-7.
14. Chevalier P., Dacosta A, Defaye P et al. Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. J Am Coll Cardiol 1998,31:57-61.
15. Chierchia S, Davies G, Berkenboom G, Crea F, Crean P, Maseri A. a-Adrenergic receptors and coronary spasm: an elusive link. Circulation 1984;69:8-14.
16. Cipnano PR, Guthaner DF, Orlick AE, Ricci DR, Wexler L, Silverman JF. The effects of ergonovine maleate on coronary arterial size. Circulation 1979;59:82-9.
17. Cocks TM, Kemp BK, Pruneau D, Angus JA. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br J Pharmacol 1993;110: 360-8.
18. De Caterina R, Carpeggiani C, L'Abbate A. A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina: evidence against a role for serotonin in the genesis of coronary vasospasm. Circulation 1984;69:889-94.
19. de Groot AN, Vree TB, Hekster YA, van den Biggelaar-Martea M, van Dongen PW, van Roosmalen J. Pharmacokinetics and bioavailability of oral ergometrine in male volunteers. Biopharmac Drug Dispos 1994;15:65-73.
20. Egashira K, Inou T, Yamada A, Hirooka Y, Takeshita A. Preserved endothelium-dependent vasodilation at the vasospastic site in patients with variant angina. J Clin Invest 1992,89:1047-52.
21. Fester A. Provocative testing for coronary arterial spasm with ergonovine maleate. Am J Cardiol 1980;46:338-40.
22. Fleck E, Auch-Schwelk W, Frantz E, Krackhardt F, Oswald H, Sauer HU. Diagnose der dynamischen Läsion. Z Kardiol 1993;82: Suppl 5:23-32.
23. Freedman SB, Chierchia S, Rodriguez-Plaza L, Bugiardini R, Smith G, Maseri A. Ergonovine-induced myocardial ischemia: no role for serotonergic receptors? Circulation 1984;70:178-83.
24. Fukai T, Egashira K, Hata H et al. Serotonin-induced coronary spasm in a swine model. A minor role of defective endothelium-derived relaxing factor. Circulation 1993;88:1922-30.
25. Fukai T, Koyanagi S, Takeshita A. Role of coronary vasospasm in the pathogenesis of myocardial infarction: study in patients with no significant coronary stenosis. Am Heart J 1993;126: 1305-11.
26. Ginsburg R, Bristow MR, Kantrowitz N, Baim DS, Harrison DC. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J 1981;:819-22.
27. Hackett D, Larkin S, Chierchia S, Davies G, Kaski JC, Maseri A. Induction of coronary artery spasm by a direct local action of ergonovine. Circulation 1987;75:577-82.
28. Harding MB, Leithe ME, Mark DB et al. Ergonovine maleate testing during cardiac catheterization: a 10-year perspective in 3,447 patients without significant coronary artery disease or Prinzmetal's variant angina. J Am Coll Cardiol 1992;20:107-11.
29. Heupler FA Jr. Syndrome of symptomatic coronary arterial spasm with nearly normal coronary arteriograms Am J Cardiol 1980;45:873-81.
30. Holtz J, Held W, Sommer O, Kuhne G, Bassenge E. Ergonovine-induced constrictions of epicardial coronary arteries in conscious dogs. a-adrenoceptors are not involved. Basic Res Cardiol 1982;77:278-91.
31. Igarashi Y, Tamura Y, Suzuki K et al. Coronary artery spasm is a major cause of sudden cardiac arrest in survivors without underlying heart disease. Coronary Artery Dis 1993;4:177-85.
32. Ito A, Shimokawa H, Kadokami T et al. Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo. J Clin Invest 1995;96:1288-94.
33. Ito A, Shimokawa H, Nakaike R et al. Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. Circulation 1994;90:2425-31.
34. Kaski JC, Crea F, Meran DO et al. Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina. Circulation 1986;74:1255-65.
35. Katsumata N, Shimokawa H, Seto M et al. Enhanced myosin light chain phosphorytations as a central mechanism for coronary spasm in a swine model with interleukin-1β. Circulation 1997;96: 4357-63.
36. Kuga T, Egashira K, Inou T, Takeshita A. Correlation of basal coronary artery tone with constrictive response to ergonovine in patients with variant angina. J Am Coll Cardiol 1993;22:144-50.
37. Kuga T, Egashira K, Mohri M et al. Bradykinin-induced vasodilation is impaired at the atherosclerotic site but is preserved at the spastic site of human coronary arteries in vivo. Circulation 1995;92:183-9.
38. Kugiyama K, Yasue H, Okumura K et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996;94:266-72
39. Kushwaha S, Lythall D, Maseri A, Mitchell A, Yacoub M. Coronary reactivity to ergonovine-possible relationship to accelerated coronary arterial disease in cardiac transplant recipients. Eur Heart J 1991;12:520-5.
40. Lablanche JM, Bauters C, Leroy F, Bertrand ME. Prevention of coronary spasm by nicorandil: comparison with nifedipine. J Cardiovasc Pharmacol 1992;20:Suppl 3:S82-5.
41. Lombardi M, Morales MA, Michelassi C, Moscarelli E, Distante A, L'Abbate A. Efficacy of isosorbide-5-mononitrate versus nifedipine in preventing spontaneous and ergonovine-induced myocardial ischaemia. A double-blind, placebo-controlled study. Eur Heart J 1993;14:845-51.
42. Mark DB, Califf RM, Morris KG et al. Clinical characteristics and long-term survival of patients with variant angina. Circulation 1984;69:880-8.
43. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. (Review). Circulation 1990;81:1983-91.
44. Maseri A, Parodi O, Severi S, Pesola A. Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 szintigraphy Circulation 1976;54:280-8.
45. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991,324:648-54.
46. Morales MA, Reisenhofer B, Rovai D, Moscarelli E, Distante A, L'Abbate A. Hyperventilation-echocardiography test for the diagnosis of myocardial ischaemia at rest. Eur Heart J 1993;14: 1088-93.
47. Monta H, Ohmori K, Matsuyama T, Mizushige K, Matsuo H. A new noninvasive method of diagnosing vasospastic angina based on dilation response of the left main coronary artery to nitroglycerin as measured by echocardiography. J Am Coll Cardiol 1996;27:1450-7
48. Myerburg RJ, Kessler KM, Mallon SM et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm (see comments). N Engl J Med 1992;326:1451-5.
49. Nakamura T, Furukawa K, Uchiyama H, Seo Y, Okuda S, Ebizawa T. Stent placement for recurrent vasospastic angina resistant to medical treatment Cathet Cardiovasc Diagn 1997;42: 440-3.
50. Nakao K, Ohgushi M, Yoshimura M et al. Hyperventilation as a specific test for diagnosis of coronary artery spasm. Am J Cardiol 1997;80:545-9.
51. Nesto RWZSW, Kowalchuk J, Kenigsberg AE, Shurmur SW, MCAuliffe LS. Frequency of symptoms suggestive of dynamic coronary artery disease in patients referred for coronary angiography. Am J Cardiol 1989;64:1374-6.
52. Nobuyoshi M, Abe M, Nosaka H et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J 1992;124:32-8.
53. Nobuyoshi M, Tanaka M, Nosaka H et al. Progression of coronary atherosclerosis: is coronary spasm related to progression? J Am Coll Cardiol 1991;18:904-10.
54. Okumura K, Yasue H, Horio Y et al. Sensitivity intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988;12:883-8.
55. Okumura K, Yasue H, Ishizaka H, Ogawa H, Fujii H, Yoshimura M. Endothelium-dependent dilator response to substance P in patients with coronary spastic angina. J Am Coll Cardiol 1992;20:838-44.
56. Ozaki Y, Keane D, Serruys PW. Fluctuation of spastic location in patients with vasospastic angina: a quantitative angiographic study. J Am Coll Cardiol 1995;26:1606-14.
57. Previtali M, Ardissino D, Barberis P, Panciroli C, Chimienti M, Salerno JA. Hyperventilation and ergonovine tests in Prinzmetal's variant angina pectoris in men. Am J Cardiol 1989;63:17-20.
58. Previtali M, Panciroli C, De Ponti R, Chimienti M, Montemartini C, Salerno JA. Time-related decrease in sensitivity to ergonovine in patients with variant angina. Am Heart J 1989;117:92-9.
59. Prinzmetal M, Kennamer R, Merliss R, Wada T, Bor N. A variant form of angina pectoris. Am J Med 1959;27:375-88.
60. Rabinowitz A, Dodek A, Carere RG, Webb JG. Stenting for treatment of coronary vasospasm Cathet Cardiovasc Diagn 1996;39:372-5.
61. Ricci DR, Orlick AE, Cipriano PR, Guthaner DF, Harrison DC Altered adrenergic activity in coronary arterial spasm: insight into mechanism based on study of coronary hemodynamics and the electrocardiogram. Am J Cardiol 1979;43:1073-9.
62. Schweiger MJ, McMahon RP, Terrin ML et al. for the TIMI Investigators. Comparison of patients with < 60% to > 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. Coronary Artery Dis 1994;74:105-10.
63. Shimizu H, Lee JD, Ogawa KB et al. Efficacy of denopamine, a beta 1 adrenoceptor agonist, in preventing coronary artery spasm. Jpn Circ J 1993;57:175-82.
64. Shirai K, Nii T, Imamura M et al. Low serum apolipoprotein A-I level in patients with vasospastic angina. Am Heart J 1993;125: 320-3.
65. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993;87:76-9.
66. Suzuki Y, Tokunaga S, Ikeguchi S et al. Induction of coronary artery spasm by intracoronary acetylcholine: comparison with intracoronary ergonovine. Am Heart J 1992;124:39-47.
67. Tanaka H, Yamakado T, Emi Y, Nabeshima K, Itoh S, Nakano T. Interferon-induced coronary vasospasm. A case history. Angiology 1995;46:1139-43.
68. Toyo-oka T, Aizawa T, Suzuki N et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991;83:476-83
69. Vanhoutte PM, Shimokawa H. Endothelium-derived relaxing factor and coronary vasospasm. Circulation 1989;80:1-9.
70. Verheye S, Maione A, de Bruyne B, Heyndrickx GR, Wijns W. Stentimplantation for treatment of refractory variant angina. Circulation 1997;96:I-275.abstract.
71. Walling A, Waters DD, Miller D, Roy D, Pelletier GB, Theroux P. Long-term prognosis of patients with variant angina. Circulation 1987;76:990-7.
72. Waters DD, Miller DD, Szlachcic J. Factors influencing the long-term prognosis of treated patiens with variant angina. Circulation 1983;68:258-65.
73. Yamagishi M, Miyatake K, Tarnai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments J Am Coll Cardiol 1994;23: 352-7.
74. Yamamoto H, Yoshimura H, Noma M et al. Preservation of endothelium-dependent vasodilation in the spastic segment of the human epicardial coronary artery by substance P. Am Heart J 1992;123:298-303.
75. Yang Z, Richard V, von Segesser L et al. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human coronary arteries. A new mechanism of vasospasm? Circulation 1990;82:188-95.
76. Yasue H, Horio Y, Nakamura N et al. Induction of coronary artery spasm by acetylcholine in patients with variant angina: possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 1986;74:955-63.
77. Yasue H, Nagao M, Omote S, Takizawa A, Miwa K, Tanaka S. Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion. Circulation 1978;58:56-62.
78. Yasue H, Takizawa A, Nagao M et al. Long-term prognosis for patients with variant angina and influential factors. Circulation 1988;78:1-9.
79. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S, Akiyama F. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974;50:534-9.
80. Zeiher AM, Drexler H, Wollschläger H, Just II. Modulation of coronary vasomotor tone in humans - progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391-401.
81. Zeiher AM, Goebel H, Schächinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995;91:941-7.
82. Zeiher AM, Schächinger V, Weitzel SH, Wollschläger H, Just H. Intracoronary thrombus formation causes focal vasoconstriction of epicardial arteries in patients with coronary artery disease. Circulation 1991;83:1519-25.